Hyperuricemia

The FDA ( U.S. Food and Drug Administration ) has granted accelerated approval to Rozlytrek ( Entrectinib ), a treatment...


The aim of a study was to investigate the prevalence of monosodium urate ( MSU ) crystal deposits, indicative for...


The FDA ( Food and Drug Administration ) has approved Siltuximab ( Sylvant ), for the treatment of patients with...


The FDA ( Food and Drug Administration ) has approved Sylvant ( Siltuximab ) for the treatment of patients with...


Siltuximab ( Sylvant ) is an anti-interleukin-6 ( IL-6 ) chimeric monoclonal antibody that binds to human IL-6.1 IL-6 is...


The role of hyperuricemia in disease progression of autosomal dominant polycystic kidney disease ( ADPKD ) has not been defined...


Pegloticase ( Krystexxa ) is a potential new treatment option for patients with chronic gout intolerant to other urate-lowering therapies.An...